Author: Mohapi, Sephekana Samuel
Author: Samuels, Veneshley
Similar Items: Inhibition of a Mycothiol biosynthetic enzyme and a detoxification enzyme as anti-tubercular drug targets
- Development of a drug discovery protocol through the expression of key mycothiol biosynthetic enzymes for Mycobacterium tuberculosis
- The expression and drug targeting of parasitic hypoxanthine-guanine phosphoribosyltransferase (HGPRT)
- Synthesis of analogues of mycothiol as possible inhibitors of enzymes in the biosynthesis of mycothiol
- Cloning, expression, purification and drug targeting of Plasmodium falciparum hypoxanthine guanine xanthine phosphoribosyltransferase (HGXPRT)
- Metal complexes of anti-tubercular drugs
- Investigating domain-selective angiotensin converting enzyme inhibition and oxidative inactivation
Similar Items: Investigation of mycobacterial cell wall genes and their requirement for survival in immune related stressful conditions
- Barriers to tuberculosis drug discovery: the mycobacterial cell wall
- Probing the Mycobacterial Cell Envelope: CRISPR interference-mediated investigation of two essential genes in the galactan biosynthetic pathway
- Mycobacterial strain diversity : impact on the host immune response
- Astrocyte-mediated immune modulation during mycobacterial infection
- Development of functional immune readouts for the confirmation of mendelian susceptibility to mycobacterial disease and related primary immunodeficiencies
- Investigation of the potential of Spleen Tyrosine Kinase (SYK) as a target for host-directed therapy during mycobacterial infection in macrophages